6W4E | pdb_00006w4e

NMR-driven structure of KRAS4B-GTP homodimer on a lipid bilayer nanodisc


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 3000 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

wwPDB Validation 3D Report Full Report

Validation slider image for 6W4E

This is version 1.2 of the entry. See complete history

Literature

Two Distinct Structures of Membrane-Associated Homodimers of GTP- and GDP-Bound KRAS4B Revealed by Paramagnetic Relaxation Enhancement.

Lee, K.Y.Fang, Z.Enomoto, M.Gasmi-Seabrook, G.Zheng, L.Koide, S.Ikura, M.Marshall, C.B.

(2020) Angew Chem Int Ed Engl 59: 11037-11045

  • DOI: https://doi.org/10.1002/anie.202001758
  • Primary Citation Related Structures: 
    6W4E, 6W4F

  • PubMed Abstract: 

    KRAS homo-dimerization has been implicated in the activation of RAF kinases, however, the mechanism and structural basis remain elusive. We developed a system to study KRAS dimerization on nanodiscs using paramagnetic relaxation enhancement (PRE) NMR spectroscopy, and determined distinct structures of membrane-anchored KRAS dimers in the active GTP- and inactive GDP-loaded states. Both dimerize through an α4-α5 interface, but the relative orientation of the protomers and their contacts differ substantially. Dimerization of KRAS-GTP, stabilized by electrostatic interactions between R135 and E168, favors an orientation on the membrane that promotes accessibility of the effector-binding site. Remarkably, "cross"-dimerization between GTP- and GDP-bound KRAS molecules is unfavorable. These models provide a platform to elucidate the structural basis of RAF activation by RAS and to develop inhibitors that can disrupt the KRAS dimerization. The methodology is applicable to many other farnesylated small GTPases.


  • Organizational Affiliation
    • Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, M5G 1L7, Canada.

Macromolecule Content 

  • Total Structure Weight: 152.84 kDa 
  • Atom Count: 10,576 
  • Modeled Residue Count: 764 
  • Deposited Residue Count: 770 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Apolipoprotein A-IA,
B [auth D]
200Homo sapiensMutation(s): 0 
Gene Names: APOA1
UniProt & NIH Common Fund Data Resources
Find proteins for P02647 (Homo sapiens)
Explore P02647 
Go to UniProtKB:  P02647
PHAROS:  P02647
GTEx:  ENSG00000118137 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP02647
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
GTPase KRasC [auth B],
D [auth C]
185Homo sapiensMutation(s): 0 
Gene Names: KRASKRAS2RASK2
EC: 3.6.5.2
UniProt & NIH Common Fund Data Resources
Find proteins for P01116 (Homo sapiens)
Explore P01116 
Go to UniProtKB:  P01116
PHAROS:  P01116
GTEx:  ENSG00000133703 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP01116
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
17F

Query on 17F



Download:Ideal Coordinates CCD File
BB [auth D]
CB [auth D]
DB [auth D]
DC [auth C]
EB [auth D]
BB [auth D],
CB [auth D],
DB [auth D],
DC [auth C],
EB [auth D],
EC [auth C],
FB [auth D],
FC [auth C],
IC [auth C],
JC [auth C],
OB [auth B],
PB [auth B],
QB [auth B],
S [auth A],
T [auth A],
Z [auth A]
O-[(S)-({(2R)-2,3-bis[(9Z)-octadec-9-enoyloxy]propyl}oxy)(hydroxy)phosphoryl]-L-serine
C42 H78 N O10 P
WTBFLCSPLLEDEM-JIDRGYQWSA-N
PCW

Query on PCW



Download:Ideal Coordinates CCD File
AA [auth D]
AB [auth D]
AC [auth C]
BA [auth D]
BC [auth C]
AA [auth D],
AB [auth D],
AC [auth C],
BA [auth D],
BC [auth C],
CA [auth D],
CC [auth C],
DA [auth D],
E [auth A],
EA [auth D],
F [auth A],
FA [auth D],
G [auth A],
GA [auth D],
GC [auth C],
H [auth A],
HA [auth D],
HC [auth C],
I [auth A],
IA [auth D],
IB [auth B],
J [auth A],
JA [auth D],
JB [auth B],
K [auth A],
KA [auth D],
KB [auth B],
L [auth A],
LA [auth D],
LB [auth B],
M [auth A],
MA [auth D],
MB [auth B],
N [auth A],
NA [auth D],
NB [auth B],
O [auth A],
OA [auth D],
P [auth A],
PA [auth D],
Q [auth A],
QA [auth D],
R [auth A],
RA [auth D],
SA [auth D],
TA [auth D],
TB [auth C],
U [auth A],
UA [auth D],
UB [auth C],
V [auth A],
VA [auth D],
VB [auth C],
W [auth A],
WA [auth D],
WB [auth C],
X [auth A],
XA [auth D],
XB [auth C],
Y [auth A],
YA [auth D],
YB [auth C],
ZA [auth D],
ZB [auth C]
1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE
C44 H85 N O8 P
SNKAWJBJQDLSFF-NVKMUCNASA-O
GSP

Query on GSP



Download:Ideal Coordinates CCD File
GB [auth B],
RB [auth C]
5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE
C10 H16 N5 O13 P3 S
XOFLBQFBSOEHOG-UUOKFMHZSA-N
MG

Query on MG



Download:Ideal Coordinates CCD File
HB [auth B],
SB [auth C]
MAGNESIUM ION
Mg
JLVVSXFLKOJNIY-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 3000 
  • Conformers Submitted: 20 
  • Selection Criteria: structures with the lowest energy 

Structure Validation

View Full Validation Report



Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Canadian Institutes of Health Research (CIHR)Canada--

Revision History  (Full details and data files)

  • Version 1.0: 2020-04-15
    Type: Initial release
  • Version 1.1: 2020-07-08
    Changes: Database references
  • Version 1.2: 2024-05-01
    Changes: Data collection, Database references